Tamtam Try Tamtam free
Humana logo

Humana account plan

Healthcare services and innovation

At a glance

Humana is a U.S. health insurer focused on Medicare Advantage, with CenterWell care services, 2025 revenues of $129,664 million and 67,060 associates.

Humana provides health insurance, mainly Medicare Advantage, stand-alone prescription drug plans, Medicaid and TRICARE military services, and runs CenterWell, which offers senior primary care, home health and pharmacy services. Government programmes accounted for approximately 93% of its 2025 premiums and services revenue. In 2025 total revenues were $129,664 million and net income $1,203 million, with approximately 67,060 associates at December 31, 2025. Medical membership reached 17,912,200 at June 30, 2026.

Business units

Strategic priorities

Return to a sustainable MA margin by 2028
Humana is committed to returning to a sustainable pre-tax margin of at least 3% in 2028 and unlocking the earnings potential of the business by 2028, as laid out at its 2025 Investor Day.
Top Quartile Star Ratings
After a decline in 2025 Star Ratings, Humana exceeded its goal of Top Quartile results in the 2027 Star Ratings (Bonus Year 2028) released on October 8, 2026.
Membership growth across Medicare
Approximately 25% individual MA growth expected in 2026, about 1,000,000 PDP members and about 150,000 group MA members; a statewide Illinois Medicaid contract starts in January 2027.
Grow CenterWell primary care
60 to 70 new centres and 120,000 to 140,000 net new patients planned for 2026 through M&A, same-store growth, IPA expansion and de novo openings.
Cost structure transformation
Value creation initiatives re-align the cost structure, operating model and technology footprint; the consolidated operating cost ratio is guided to 10% plus or minus 25 bps in 2026, down from 11.5% adjusted in 2025.

Latest results

In Q2 2026 (quarter ended June 30), total revenues rose 26.2% to $40,867 million, driven by Medicare membership growth and higher per-member premiums, and net income attributable to Humana was $694 million against $545 million. The consolidated benefit ratio rose to 91.1% from 89.7%, reflecting the Star Ratings revenue headwind and new members running at a higher benefit ratio, while the operating cost ratio fell 120 basis points to 9.8%. For the six months, revenues were $80,515 million (+24.8%). Humana affirmed FY 2026 Adjusted EPS of at least $9.00, down from $17.14 in 2025, and holds a virtual investor update on December 10, 2026.

Investments and deals

MaxHealth acquisition
A Florida primary care platform acquired on February 13, 2026 for approximately $908 million net of cash acquired.
Value creation initiatives
Charges of $449 million in 2025, including $329 million of severance, and $154 million in H1 2026, with more expected.
Capital expenditure
Net capital expenditures of $523 million in 2025, mainly information technology and primary care facilities, and $253 million in H1 2026.
Gentiva divestiture
Agreement to divest all or substantially all of its minority interest in Gentiva, valued at approximately $900 million.
Contingent capital
$1.5 billion of P-Caps facilities established in May 2026 and $1.0 billion of junior subordinated notes issued in March 2026.

Challenges and risks

Star Ratings revenue headwind
The number of MA plans rated 4-star or higher declined significantly in 2025, cutting 2026 quality bonus payments and earnings.
Medical and drug cost trend
Cost trend is expected in the high single digits in 2026, with pharmacy in the low double digits, and initial 2026 guidance assumed individual MA margins slightly below breakeven.
Regulatory and audit risk
CMS RADV audits, IRA Part D changes and possible restrictions on vertically-integrated arrangements; AI/ML use is listed as a source of regulatory risk.
Revenue concentration
83% of 2025 premiums and services revenue came from federal government contracts, including 14% from Florida individual MA contracts.
Litigation
A DOJ False Claims Act complaint over payments to call-centre broker partners, a TCPA class action and a securities class action.

What leadership says

“behave more like a consumer health care company, to the degree that there is such a thing in the U.S. right now, as opposed to a traditional insurance company.”

Jim Rechtin, President and CEO · Fortune interview, November 10, 2025

“we have almost no tools to collect feedback from our customers.”

Jim Rechtin, President and CEO · Fortune interview, November 10, 2025

“Billing and collecting costs too much. Distribution costs too much.”

Jim Rechtin, President and CEO · Fortune interview, November 10, 2025

“we use AI tools to get to a faster yes. The nos go to a doctor”

Jim Rechtin, President and CEO · Fortune interview, November 10, 2025, on prior authorization

Where a supplier can help

Customer feedback and experience tools
The CEO wants Humana to behave like a consumer health care company and says it has almost no tools to collect customer feedback, which fits the Star Ratings priority.
Administrative cost reduction
The cost-structure transformation and the CEO's view that billing, collecting and distribution cost too much open room for revenue-cycle, automation and outsourcing suppliers.
Compliant AI for sales and care
AI is used in prior authorization and broker tools while AI/ML use is a listed regulatory risk, so AI governance and audit tooling is relevant.
Primary care roll-out
Opening 60 to 70 centres and integrating MaxHealth calls for clinic fit-out, staffing, scheduling and clinician-productivity solutions.
Risk-adjustment and audit readiness
RADV audits of all eligible MA contracts every year create demand for coding accuracy and documentation support.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Humana?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Humana

What does Humana do?

Humana sells health insurance, mainly Medicare Advantage, prescription drug plans and Medicaid, and runs CenterWell senior primary care, home health and pharmacy services.

What was Humana's revenue in 2025?

Total revenues were $129,664 million in 2025 (+10.1%), with net income of $1,203 million.

How many employees does Humana have?

Approximately 67,060 associates at December 31, 2025.

Who leads Humana?

James A. Rechtin has been President and CEO since July 1, 2024; Celeste M. Mellet has been CFO since January 2025.

What is Humana's strategy?

Humana aims to return to a sustainable MA pre-tax margin of at least 3% in 2028 through membership growth, Top Quartile Star Ratings, CenterWell expansion and cost discipline.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)